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ABSTRACT
Gestational diabetes is first diagnosed during pregnancy. There are Evidences of increased
oxidative stress in pregnant women and on the other hand, the role of oxidative stress and
impaired antioxidant system in complications during pregnancy such as premature delivery and
miscarriage have been proved.   Given that peroxidase as an enzymatic antioxidant and alpha-
amylase as salivary enzyme, are important variables associated with diabetes, and regarding
contradictory articles about their increase or decrease, assessing both factors in terms of reducing
the complications of diabetes. In this cross-sectional study, unstimulated saliva of 31 patients with
gestational diabetes and 59 non-diabetic pregnant patients were collected and amounts of salivary
peroxidase alpha-amylase were assessed separately in these individuals. Data obtained from the
study was statistically analyzed using descriptive statistics methods and Mann-Whitney test. P
<0.05 was considered as significant in all tests. The mean value of salivary peroxidase level was
-54.55 ± 48.7 in women with gestational diabetes and 24.71 ± 8.77 in non-diabetic pregnant
women. The mean value of amylase level in the saliva was 609387.1± 132534.38 in women with
gestational diabetes and 478559 ±.8581000.41 in non-diabetic pregnant women. According to the
data obtained from this study, it could be stated that in women with gestational diabetes the level
of alpha-amylase is increased but the level of salivary peroxidase is reduced, compared with non-
diabetic pregnant women, but none of these changes are significant.
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INTRODUCTION
Unlike the previous categories which were
based on the age of onset or type of treatment,
currently diabetes is classified as the following
based on the pathogenesis that can lead to
hyperglycemia:
I Type 1 diabetes (cell destruction, usually
leading to absolute insulin deficiency): A.
immune-mediated and Idiopathic
II Type 2 diabetes (from dominant form of
insulin resistance with partial insulin
deficiency to dominant form of insulin
secretion defect with variable insulin
resistance)
III Other specific types of diabetes
IV Gestational diabetes mellitus1-4
V Gestational diabetes is caused by a disorder
in carbohydrate tolerance that is first
diagnosed during pregnancy5-8.
Women who are at average risk, are
screened with 50 g oral glucose (GCT) at 28-24
weeks of gestation, but in high risk women including
obese individuals, family history of diabetes,
previous history of gestational diabetes, impaired
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glucose metabolism or Glucosuria, history of
macrosomia or malformations in previous newborns
and smoking during pregnancy, as soon as
possible, they are evaluated in accordance with
the above-mentioned guideline. If the result is
negative, the test is repeated again in 28-24 weeks
of pregnancy or when a person has symptoms and
if the oral glucose tolerance test happens to be
higher than recommended for two or more times,
the person is considered to have gestational
diabetes3, 5, 9.
Antioxidants are compounds that can
neutralize free radicals and reactive oxygen species
and prevent oxidation of lipids, nucleic acids and
proteins. Antioxidants are able to act at four levels:
(A) Preventing formation of free radicals
(B) Preventing or interrupting the activity of free
radicals after their formation
(C) To repair damages resulting from radical
activity
(D) Increasing the excretion or absorption of
damaged molecules10
Oxidative stress occurs due to an
imbalance between the formations of reactive
oxygen species (ROS) and antioxidant defenses.
In normal conditions antioxidants prevent
overproduction of ROS that lead to tissue damage11-
13
.
The role of oxidative stress and impaired
antioxidant system in various complications during
pregnancy, such as preterm delivery, fetal growth
restriction, preeclampsia, and abortion has been
demonstrated14.  Moreover, there are evidences for
increased oxidative stress in diabetic pregnant
women especially with type II diabetes12.
There are two types of antioxidants in the
body (1) enzymatic, (2) non-enzymatic. The most
important enzymatic antioxidants include
superoxide dismutase (SOD), catalase and
glutathione peroxidase (GPO)15.
Saliva is a complex liquid consisting of
water and organic and inorganic components and
contains buffers, enzymes, growth factors,
cytokines, immunoglobulins, mucins and other
glycoproteins (1). Saliva has various defense
systems including the antioxidant defense system
that serves as the first line of defense against
oxidative stress (2).
Saliva plays major roles including
defensive functions that includes Lubrication,
antimicrobial activity, growth factors, maintaining
integrity of mucosa, washing and clearing the
surface of mucosa and teeth, buffered properties
and mineralization. Other functions of saliva include
assisting in the preparation of ingested food,
chewing and digestion, taste and speech.  These
multiple compounds in saliva, play roles not only in
protecting oral tissues, they may be an indicator of
some systemic diseases as well. So that salivary
biomarkers are used as indicator tools for evaluating
public health and early diagnosis of diseases (1,
2). Saliva, as a clinical tool, has many advantages
over serum, because the collection and storage of
saliva is easy and could be collected in sufficient
amount for analysis. Besides, collecting saliva, as
a non-invasive sampling techniques, causes less
anxiety and discomfort in patients and provides a
simple preparation of samples for long-term
evaluation of one particular condition13.
Since diabetes can lead to a Variety of
other diseases including cardiovascular diseases
and regarding the fact that peroxidase as an
enzymatic antioxidant and Alfa amylase as a
salivary enzyme, are two important variables
associated with diabetes, and also considering the
contradictory articles about their increase or
decrease, it is very important to investigate both
factors with regard to reducing the complications of
diabetes16.
Amylase is derived from the Greek word
“amilone” which means starch. The main sources
of Amylase in human is pancreas and salivary gland
although it could be found in other tissues in small
amounts. Alpha amylase enzyme belongs to
Glycosyl hydrolase family of enzymes and is locally
produced in the oral cavity by the salivary glands.
Its biological function is to digest macromolecules
such as carbohydrates and starch. Salivary alpha
amylase is considered one of the most important
salivary enzymes and is produced primarily in the
parotid glands16, 17.
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For several years, due to low levels of
serum amylase, disseminated pancreatic
degradation was considered secondary to the
advanced pancreatic diseases such as chronic
pancreatitis. Recently, several clinical studies have
shown that low levels of serum amylase is
associated with the metabolic syndrome and
diabetes. Impairment in serum amylase is
associated with insulin-deficiency in patients with
type 1 diabetes and with lower incidence with type
2 diabetes and pathogenesis of insulin resistance
in obese animal models. Since serum amylase is
from two types, salivary type and pancreatic type, it
is necessary to differentiate between types of
amylase for accurate clinical diagnosis. However,
measurement of serum amylase is useful to
determine the pathogenesis of many diseases16, 17.
Diabetes not only causes defects in the
metabolism of carbohydrates, but also associates
with abnormal metabolism of fats and proteins as
well. Thus, three key enzymes including lipase,
protease and amylase are important in the treatment
of diabetes because they help to digest all of these
three groups of food (protein, fats and
carbohydrates)16, 17.
It is also much safer for Experts to collect
saliva rather than blood test that pose health
workers with the risk of contact with hepatitis viruses
or HIV. Therefore, the diagnosis of disease based
on the collection of saliva will be much more
accessible and cheaper than other methods and
entails minimal risk to the patient1, 18. Diabetes
increases the production of free radicals and is
associated with disorders in antioxidant defenses
and since few studies have studied the role of
oxidative stress in diabetic pregnancy. Given the
limited and contradictory studies in this area and in
particular with regard to the importance of
antioxidants in the prevention and treatment of many
diseases and cancers, the aim of this study was to
investigate amylase and peroxidase levels in the
saliva of women with gestational diabetes in
comparison with non-diabetic pregnant women.
MATERIALS AND METHODS
In this cross-sectional study, the study
population was selected After completing the
consent form from patients referred to private clinics
and Oral Medicine Department of Tabriz Dental
medicine School and Al-Zahra Hospital in Tabriz in
1394 (2015). Being Diabetic and non-diabetic and
having any systemic disease and drug consumption
in pregnant women was confirmed by obstetricians
using approved check list before sampling.
According to the recommendation of American
Diabetes Association (ADA) on routine screening
for GDM during pregnancy, serum screening for
GDM takes place between 26 to 30 weeks of
pregnancy19. Diagnosis of diabetes is made when
FPG is 126 mg / 100 ml or more or when blood
sugar, two hours after taking 75 -100 grams of
glucose, is 200 mg / 100 ml or more in two repeated
tests3. All subjects were matched for age, Body Mass
Index (BMI) and pregnancy with the control group.
Inclusion and exclusion criteria: 20-40
years old pregnant women having gestational
diabetes and under diabetes treatment, lack of any
systemic diseases in the last three months, no
history of diabetes before, not using any other drug
no-related with diabetes, no history of smoking and
not using drugs that impairs the balance of
antioxidant defense system. This information was
obtained by studying medical records and clinical
examination.
Saliva Collection method: Saliva sample
collection was performed by Spitting method in
which, the patient was allowed to collect saliva in
the mouth and then transfer it into a special sterile
plastic tubes (falcon).  This is usually done every 60
seconds for 15-5 minutes.   To get unstimulated
samples, the person was asked to avoid eating or
drinking or any other oral stimulation for 90 minutes
before collecting the saliva. Using this method,
approximately 5 mL of saliva was collected. Saliva
was collected for all subjects between 8 to 9 am
(fasting) in order to prevent day and night
changes20, 21. Collected Saliva was immediately put
on ice and transported to the laboratory and
centrifuged at 800g for 10 min at 4 ° C to separate
squamous cells and debris. The samples were
frozen at -80 ° C until preparation of all samples
were21, 22. When all Samples were collected, the
necessary tests were carried out using purchased
kits.
502 AHARI et al., Biomed. & Pharmacol. J.,  Vol. 9(2), 499-506 (2016)
Measuring salivary peroxidase enzyme
activity: Peroxidase was measured using the glycol
method for which Bioris kit was used. In this method,
glutathione is oxidized by hydro-peroxide, and then
is converted to glutathione reduced form in the
presence of glutathione reductase (GR).
2GSH + ROOH → ROH + GSSG + H2O
NADP+ + 2GSH → GSSG + NADPH + H+
First of all, 50 ml saliva incubated with ml
1 dilution buffer for 5 minutes and then 1 ml Drubkin
solution was added (dilution factor 1 to 41). Then,
in a quartz cuvette (test cuvette) 10 µlit of diluted
sample + 500 µlit reagent + 20 µlit Common
hydrogen peroxide was added. In another cuvette
other (blank cuvette) 10 µlit distilled water +500 µlit
reagent + 20µlit Common hydro-peroxide is poured
and both cuvettes were mixed separately and
placed in spectrophotometer. After one minute,
absorption of test and blank cuvettes was read. In 1
and 2 minutes later the absorption of both cuvettes
was read again. To calculate the glutathione
peroxidase activity, kit instructions was followed
using the following formula:
U/L= 8412 × ΔA/min
The activities of blank and test cuvettes
were calculated separately and then the activity of
blank was subtracted from the activity of test.
Peroxidase unit of measurement is unit / lit. After
measuring the peroxidase activity in both groups
(women with gestational diabetes and healthy
women), the values were compared to each other.
Measuring alpha- amylase: After sending
saliva samples to the laboratory,   for producing a
pure solution and separation of impurities, it was
centrifuged at 3000 rpm for 3-5 minutes that resulted
in the formation of two phases in Falcon tube. The
lower contains impurities and the upper phase is
pure saliva. In the next step, was sample dilution by
1:120 For this purpose, 800 µlit distilled water and
20 ml of pure saliva were shed in a test tube and
1:40 dilution was obtained. Then 1:30 dilution was
obtained by shedding 200 ml of distilled water in a
1.5 micro tubes and 100 µlit of 1:40 dilution was
added to it and then put the mixture in a shaker for
2-3 minutes. The sample finally was diluted 1:120.
First, 1 µlit  of  Reagent 1 which was alpha amylase
(Mg / l) was poured in falcon tube  and  placed in 37
° C water bath for 5 minutes Along with the blank
tube containing 1 µlit of Reagent 1 . Then to all
tubes except the blank tube, 20 microliter sample
with dilution of 1:120 was added and placed again
in 37 ° C water bath for 2-3 minutes16.
Finally, the data obtained from the study
were analyzed by descriptive statistics (mean,
standard deviation and frequency percentage) using
SPSS.16 statistical analysis software. In This study
p-value< 0.05 was considered statistically significant.
For comparing values of the parameters, due to non-
normal distribution of data in the case and control
groups, Mann-Whitney test was used and always p
<0.05 was considered significant. In addition to
graphics, Kolmogorov-Smirnov test was also used
to show normal distribution of parameters. It should
be noted that in all patients before entering the study,
written informed consent was obtained and patients
were free to leave the study in case of unwillingness.
RESULTS
From 90 cases, 31 cases were women with
gestational diabetes and 59 others were non-
diabetic pregnant women. Average peroxidase
levels in the saliva of women with gestational
diabetes was -54.55 ± 48.7 and in non-diabetic
pregnant women was 8.77 ± 24.71. According to
the data average, level of salivary peroxidase has
decreased in women with gestational diabetes.
However, comparison of salivary peroxidase levels
in women with gestational diabetes and non-
diabetic pregnant women with Mann-Whitney
nonparametric test  (with respect to non-normal
data) showed that this difference was not significant
(Figure A) (P-value = 0.69).
According to this study, the mean level of
amylase in the saliva of women with gestational
diabetes and non-diabetic pregnant women was
609387.1±132534.38 and 478559.85± 81000.41
respectively. According to the data average, the level
of salivary amylase has increased in women with
gestational diabetes. However, comparing these two
levels with Mann-Whitney nonparametric test (with
respect to non-normal data) showed that this difference
was not significant (Figure Two) (P-value = 0.61).
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DISCUSSION
Gestational diabetes mellitus (GDM) is
common during pregnancy and is associated with
some complications for mother and fetus. Studies
have shown that in societies that  diabetes type II is
more common, gestational diabetes is more
common as well, but the risk and onset of the
disease is quite variable23.
This disease  is one of the most common
complications of pregnancy and the prevalence of
almost 7 percent (more than two hundred thousand
people per year) of all pregnancies have been
reported in America24. This metabolic disorder with
increased severity of side effects, is an important
risk factor for the mother and child in short term and
long term. Children born to mothers with gestational
diabetes are more vulnerable to obesity, glucose
intolerance and diabetes in childhood and
adolescence. Gestational diabetes increases the
risk for the mother and fetus during pregnancy and
in later stages of life25, 26.
During normal pregnancy, oxidants, with
their physiological functions, are very in the
promotion and control cell fate and play a vital role
in the natural development through cell signaling.
Absence of increased antioxidant activity along with
an increase in oxidants leads to oxidative stress.
The level Oxidative stress is able to change the
duration and severity of symptoms. Overproduction
of ROS can damage the cell mass by acting on
proteins, fats and DNA. In the case of systemic
oxidative stress such as gestational diabetes, it
can even cause biochemical disturbances in the
fetus27-30.
In the present study, 31 pregnant women
with gestational diabetes and 59 non-diabetic
pregnant women were studied in terms of the
amount of hydrogen peroxidase antioxidant and
salivary amylase.  The mean level of peroxides in
the saliva of women with gestational diabetes was
-54.55 ± 48.7 and in non-diabetic pregnant women
was 8.77±24.71. Additionally, the mean level of
amylase in the saliva of women with gestational
diabetes was 609387.1± 132534.38 and in non-
diabetic pregnant women was 478559.85 ±
81000.41.
Various studies have examined the
salivary biomarkers which will be discussed and
compared next.   In a study that was conducted by
Kornhauser and colleagues31 about several
biomarkers, including glutathione peroxidase, it
was Concluded that the amount of this antioxidant
is significantly lower in patients with type 2 diabetes
mellitus so that The amount of this biomarker was
reduced in the study group compared to the control
group, although this reduction was not statistically
significant. The findings of Chaudhari32 and
Kinalski33 also showed that levels of peroxidase is
significantly lower.
Unlike the above mentioned studies,
Sharma and colleagues9 examining the antioxidant
levels in pregnant women suffering diabetes,
Figure 1: Comparison of salivary peroxidase
level in women with gestational diabetes and
non-diabetic pregnant women
Fig. 2: Comparison of alpha amylase in the
saliva of women with gestational diabetes and
non-diabetic pregnant women
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reported that peroxidase was significantly higher
in patients with gestational diabetes than normal
pregnant women. In another study, Tosecu and
colleagues also came to a similar result   and stated
that the amount of hydrogen peroxides in all women
with diabetes, especially in people with type 2
diabetes is significantly higher34.
These conflicting findings may be under
the influence of various factors, including
medication, duration of diabetes, gestational age,
age, gender and other factors that could be
assessed in the future research in similar samples.
However, it can be stated that oxidative
stress management, coupled with rigorous control
of blood sugar might be beneficial during both pre-
pregnancy and pregnancy , But it is unclear if taking
antioxidant supplements or eating a diet rich in
antioxidants can improve the consequences of
oxidative stress in children or not. Obviously more
studies are required to fully understand the short-
term and long-term benefits of reduced oxidative
stress during gestational diabetes30.
Indira et al.,35 in 2015, studied the saliva
of patients with type 2 diabetes and found that
diabetes alters the composition of saliva. In this
study, level of amylase was significantly lower in
the case group rather than the control group. Similar
results were also obtained by Yavuzyilmaz and
colleagues in 199636, Panchbhai and colleagues
in 201037, Nakajima et al in 2011 38 and Mufeed
and colleagues in 2014 16, which attributed it to
hormonal and metabolic changes in diabetic
patients.
In another study in which Dawood
compared the levels of alpha-amylase among
diabetic  patients39, it was observed that there is  an
inverse relationship between type 1diabetes alpha-
amylase level, this means that patients  with type 1
diabetes have  significantly lower amylase level
compared to the control group. It was also indicated
that with increasing disease duration, the more
enzymes decreased. But unlike previous studies
and  in line with the results of the present study,
evaluation of  patients with type II diabetes (39) did
not show any significant relationship with levels of
alpha-amylase  This attributable to a dire shortage
of insulin in Type I diabetes which also affects
Exocrine glands and its secretions like alpha-
amylase as well. A study in India by Reddy and
Shankarah (2011)39 demonstrated a significant
increase in levels of alpha-amylase in type II
diabetes patients which is very similar to  the
present study in terms of higher levels of alpha-
amylase in cases with the difference that the change
was not significant in the present study.
Based on the above mentioned studies, it
could be concluded that Because diabetes is a
multifactorial disease and various factors such as
race, diet, and environment play a role in its
development, and  As the antioxidant capacity of
saliva can be affected by various factors such as
the potential level of antioxidants, free radical
production, the genetic background of individuals,
food intake, smoking, physical activity, stress and
hormones,  as well as various studies on saliva
indicating that oral cavity conditions including
decays and periodontal disease are involved  in
the amount of antioxidants, Therefore, in future
studies , patients should be selected from  same
local and systemic  conditions.  About alpha-
amylase, it is also recommended that future studies
concurrent with evaluate salivary and pancreatic
alpha-amylase and check the conformity of their
results.
CONCLUSION
According to data obtained from this study
and their analysis, it could be concluded that in
women with gestational diabetes compared with
non-diabetic pregnant women, levels of alpha
amylase increased and salivary peroxidase
decreased, but none of these changes are
significant.
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